ID

34411

Beschreibung

Non-interventional Study With Pomalidomide (Imnovid®); ODM derived from: https://clinicaltrials.gov/show/NCT02075996

Link

https://clinicaltrials.gov/show/NCT02075996

Stichworte

  1. 17.01.19 17.01.19 -
Rechteinhaber

see on clinicaltrials.gov

Hochgeladen am

17. Januar 2019

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Multiple Myeloma NCT02075996

Eligibility Multiple Myeloma NCT02075996

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients with relapsed or refractory multiple myeloma patients must have received at least two prior lines of treatment (induction therapy followed by stem cell transplantation ± maintenance therapy is considered one prior therapy) and must have progressed under the most recent therapy regimen
Beschreibung

ID.1

Datentyp

boolean

adult male and female patients (at least 18 years with no upper age limit)
Beschreibung

ID.2

Datentyp

boolean

written informed consent to data collection and pseudonymized data transfer
Beschreibung

ID.3

Datentyp

boolean

the conditions of the pregnancy prevention programme must be fulfilled for all patients unless there is reliable evidence that the patient does not have childbearing potential (see summary of product characteristics imnovid®)
Beschreibung

ID.4

Datentyp

boolean

other criteria according to summary of product characteristics imnovid®
Beschreibung

ID.5

Datentyp

boolean

Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
missing patient's informed consent
Beschreibung

ID.6

Datentyp

boolean

pregnant or breast-feeding women
Beschreibung

ID.7

Datentyp

boolean

male patients, not capable of complying the required preventive measures (see summary of product characteristics imnovid®)
Beschreibung

ID.8

Datentyp

boolean

other criteria according to summary of product characteristics imnovid®
Beschreibung

ID.9

Datentyp

boolean

Ähnliche Modelle

Eligibility Multiple Myeloma NCT02075996

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
patients with relapsed or refractory multiple myeloma patients must have received at least two prior lines of treatment (induction therapy followed by stem cell transplantation ± maintenance therapy is considered one prior therapy) and must have progressed under the most recent therapy regimen
boolean
ID.2
Item
adult male and female patients (at least 18 years with no upper age limit)
boolean
ID.3
Item
written informed consent to data collection and pseudonymized data transfer
boolean
ID.4
Item
the conditions of the pregnancy prevention programme must be fulfilled for all patients unless there is reliable evidence that the patient does not have childbearing potential (see summary of product characteristics imnovid®)
boolean
ID.5
Item
other criteria according to summary of product characteristics imnovid®
boolean
Item Group
C0680251 (UMLS CUI)
ID.6
Item
missing patient's informed consent
boolean
ID.7
Item
pregnant or breast-feeding women
boolean
ID.8
Item
male patients, not capable of complying the required preventive measures (see summary of product characteristics imnovid®)
boolean
ID.9
Item
other criteria according to summary of product characteristics imnovid®
boolean

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video